This assay is intended for the in vitro qualitative measurement of Hepatitis B virus (HBV) DNA, Hepatitis C virus (HCV) RNA, and Human Immunodeficiency Virus Type 1 and 2(HIV 1 + 2) RNA in human serum or plasma samples. This assay is used for donor screening and as an auxiliary diagnosis for clinical infections of Hepatitis B virus, Hepatitis C virus and Human Immunodeficiency Virus Type 1 and 2.
• High-Efficiency Multiplexing
Simultaneously detects HBV DNA, HCV RNA, and HIV-1/2 RNA in a single reaction tube, significantly streamlining laboratory workflows and saving turnaround time.
• Maximized Blood Safety
Specifically designed and optimized for reliable donor screening, providing an essential diagnostic layer to secure the blood supply chain.
• Robust Internal Control
Utilizes advanced Armored RNA technology as a universal internal standard to prevent false negatives caused by RNA degradation or PCR inhibition.
• Advanced Anti-Contamination
Incorporates a UNG enzyme system with dUTP to actively eliminate carryover contamination, ensuring high-confidence screening results.
Product Name | AffirPrime HIV1&2/HBV/HCV |
Technology / Methodology | Multiplex Real-Time PCR / Magnetic beads extraction |
Specimen Type | Serum, Plasma (EDTA, Sodium Citrate) |
Intended Use | Donor screening and auxiliary diagnosis |
Target Pathogens | HBV DNA, HCV RNA, HIV-1/2 RNA |
Fluorescence Channels | FAM (HBV), VIC (HCV), ROX (HIV-1+2), CY5 (IC) |
LoD | HBV DNA: 5 IU/mL HCV RNA: 10 IU/mL HIV (1+2) RNA: 50 IU/mL |
Internal Control | Yes |
Storage Conditions | 2-8°C |
Shelf Life | 12 months |
Catalog. No. | Product Name | Spec. | Certificate |
M1051 | AffirPrime HIV1&2/HBV/HCV | 96 Tests/Kit | NMPA |